Table 3.
Number of cases showing qualitative contrast-enhancement feature during wash-in: cytophathology classification
| Enhancement degree | Homogeneity | Pattern | Distribution | ||||||||
| Isoenhancing | Hypoenhancing | Hyperenhancing | Homogeneous | Inhomogeneous | Centripetal | Centrifugal | Diffuse | Central | Peripheral | Diffuse | |
| Cytological diagnosis | |||||||||||
| BDA | 10 | 2 | 8 | 8 | 12 | 0 | 0 | 20 | 3 | 2 | 15 |
| BDC | 3 | 3 | 10 | 3 | 13 | 0 | 1 | 15 | 0 | 4 | 12 |
| HCC | 1 | 0 | 7 | 0 | 8 | 3 | 0 | 5 | 1 | 3 | 4 |
| P value | 0.092 | 0.067 | 0.003 | 0.260 | |||||||
BDA, bile duct adenoma; BDC, bile duct carcinoma; HCC, hepatocellular carcinoma.